热门资讯> 正文

Acurx Pharmaceuticals提交5000万美元混合货架产品

2025-07-10 05:45

纳比特(NA) 0
盛大科技(SDA) 0
Acurx Pharmaceuticals LLC Ordinary Shares(ACXP) 0

Acurx Pharmaceuticals (NASDAQ:ACXP) has filed a shelf registration to offer up to $50M in securities over time.
The offering may include common stock, preferred stock, debt securities, warrants, rights, or units, in any combination.
Securities may also be issued through conversion or exercise of other securities (e.g., preferred to common, debt to equity, or warrants to stock).
Source: SEC filing

More on Acurx Pharmaceuticals

Acurx Pharmaceuticals, Inc. (ACXP) Q1 2025 Earnings Call Transcript
Acurx signals progress in Phase 3 ibezapolstat program with $12M credit line following regulatory alignment
Seeking Alpha’s Quant Rating on Acurx Pharmaceuticals
Historical earnings data for Acurx Pharmaceuticals
Financial information for Acurx Pharmaceuticals

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。